Naproxen PCD Pharma Franchise Company
Cafoli Lifecare offers 7 Naproxen formulations in tablet form, including combination products, for its pain management and orthopaedic franchise partners. All products are manufactured at WHO-GMP certified facilities and offered with monopoly rights.
What is Naproxen?
Naproxen is a propionic-acid class non-steroidal anti-inflammatory drug (NSAID). It non-selectively inhibits the COX-1 and COX-2 enzymes, reducing prostaglandin synthesis and thereby relieving pain, inflammation and fever. It has a longer half-life than many NSAIDs, permitting twice-daily dosing. See MedlinePlus for details.
Therapeutic Applications
Naproxen is used in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, gout, musculoskeletal pain, dysmenorrhoea and acute migraine. Prescribers include orthopaedicians, rheumatologists, general physicians, gynaecologists and neurologists.
Why Naproxen is a High-Potential Molecule for Distributors
Chronic arthritis is a growing burden in India's ageing population, and Naproxen's long duration of action and comparatively favourable cardiovascular profile within the NSAID class make it a molecule physicians are comfortable continuing for months. Long treatment durations translate directly into repeat monthly orders for the franchise partner.
Why Choose Cafoli Lifecare
Cafoli offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, attractive net rates and complete promotional inputs, with 1000+ partners across India.
References
- MedlinePlus: Naproxen
- WHO Essential Medicines List
- PubChem: Naproxen
Our formulations of Naproxen find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: